In addition, the BRAF V600E mutation was significantly different in the central lymph nodes and lateral neck lymph nodes (75.3 vs. 49.3%; P=0.002) of patients with lymph node metastasis. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.